US Corporate Board Director Changes SEC Filings — March 10, 2026

10-03-2026

Craig Abrahams notified Playtika Holding Corp. of his resignation as President and Chief Financial Officer, effective April 1, 2026, with no relation to financial issues or disagreements. The board appointed Tae Lee as acting Chief Financial Officer and principal financial officer effective the same date, and updated Robert Antokol's title to Chief Executive Officer, President, and Chairperson of the Board. No changes to Antokol's compensation and no material interests or family relationships for the involved parties.

• ·Tae Lee, age 41, previously Corporate Finance Manager at Meta Platforms, Inc. from 2019-2021; MBA from Columbia Business School; BA in Economics from University of Chicago.
• ·Mr. Lee's compensation as acting CFO not yet determined; to be filed as amendment.
• ·Reference to 2025 Proxy Statement filed April 25, 2025, for Antokol's compensation and experience.
• ·No arrangements, understandings, or family relationships for Lee or Antokol; no material interests exceeding $120,000 threshold.

10-03-2026

Terrell Kirk Crews II, Executive Vice President and Chief Risk Officer of NextEra Energy, Inc., notified the company of his resignation effective March 20, 2026, to accept a chief financial officer position with another company. NextEra Energy thanked Mr. Crews for his leadership and contributions. No information on a successor or impact to operations was provided.

• ·Resignation notification date: March 5, 2026
• ·8-K filing date: March 10, 2026

10-03-2026

Harvard Bioscience, Inc. entered into an amended employment agreement with CEO John Duke effective March 6, 2026, providing a $515,000 annual base salary, a $100,000 cash bonus upon successful credit facility refinancing, up to 80% incentive compensation, and a target 75,000 RSUs for 2026 post 1:10 reverse stock split. The Board appointed Mark Frost as permanent CFO and Treasurer, effective the same date, with a $375,000 base salary, up to 60% incentive compensation, and target 30,000 RSUs for 2026 post reverse stock split. Both agreements supersede prior ones and include severance benefits for certain termination events.

• ·Duke agreement term extends to July 16, 2027, with automatic two-year renewals.
• ·Frost agreement term extends to April 10, 2027, with automatic two-year renewals.
• ·Duke prior agreement dated July 16, 2025; Frost prior agreement dated April 10, 2025.
• ·Reverse stock split (1:10) effective March 13, 2026.
• ·Frost served as Interim Financial Officer from April 10, 2025, to March 6, 2026.

10-03-2026

Cross Country Healthcare, Inc. announced the departure of James V. Redd III as Senior Vice President and Chief Accounting Officer and Phil Noe as Chief Information Officer, effective March 10, 2026, with neither departure resulting from any dispute or disagreement on accounting or financial matters. The Board appointed internal candidate Marvin Veizaga, aged 45 and previously Group Vice President, Corporate Controller since 2015, to the Chief Accounting Officer role effective the same date. Veizaga's compensation includes a base salary increase to $340,000, with short-term and long-term incentive targets each at 50% of base salary.

• ·Marvin Veizaga employed by Company since 2015; previously Vice President, Assistant Controller (2021-2023) and Vice President, Business Unit Controller (2020-2021); Senior Auditor at Deloitte & Touche LLP (2012-2015); Certified Public Accountant; Bachelor of Science in Accounting from Florida Atlantic University.
• ·No arrangement or understanding regarding Veizaga's appointment; no family relationships with directors or executives; no material interest in transactions under Item 404(a) of Regulation S-K.

10-03-2026

Westrock Coffee reported full year 2025 net sales of $1.2B, up 39.8% YoY, with strong segment growth in Beverage Solutions (+37.8% sales, +27.7% Adj EBITDA) and SS&T (+46.6% sales). However, gross profit declined 2.0% to $150.8M, net loss widened to $90.4M from $80.3M, and Q4 gross profit grew modestly 2.3% while Beverage Solutions Adj EBITDA increased only 5.4%. The company updated 2026 Consolidated Adjusted EBITDA outlook to $90M-$100M, implying 29%-44% growth over 2025.

• ·FY2025 Consolidated Adjusted EBITDA included $15.3M of Conway Facility scale-up costs vs. $12.8M prior year.
• ·Q4 2025 Consolidated Adjusted EBITDA included $1.4M of Conway Facility scale-up costs vs. $7.6M prior year.
• ·Beverage Solutions secured net leverage ratio of 3.85x as of Dec 31, 2025.
• ·Company in compliance with Credit Agreement financial covenants.
• ·2025 actual Consolidated Adjusted EBITDA of $69.7M exceeded prior outlook high of $65M.

10-03-2026

WM Technology, Inc. appointed Nicholas Rellas as a Class III director effective March 5, 2026, until the 2027 annual meeting of stockholders or until his successor is qualified. The Board determined Mr. Rellas to be an independent director under Nasdaq rules, with no arrangements or understandings regarding his selection and no reportable transactions under Item 404(a) of Regulation S-K. In connection with the appointment, he received an initial grant of restricted stock units valued at approximately $400,000, vesting in three equal annual installments.

• ·Appointment recommended by Nominating and Corporate Governance Committee.
• ·Compensation pursuant to Amended Non-Employee Director Compensation Policy.
• ·Standard indemnification agreement entered with Mr. Rellas.

10-03-2026

Xponential Fitness, Inc. announced the separation of Chief Financial Officer John Meloun effective March 9, 2026, and the appointment of Robert Julian as interim CFO effective March 16, 2026, amid a search for a permanent replacement. The company reaffirmed its fiscal year 2026 financial guidance originally provided on February 26, 2026. CEO Mike Nuzzo expressed confidence in Julian's extensive experience while thanking Meloun for his eight years of contributions.

• ·Robert Julian brings more than 30 years of financial leadership experience.
• ·Company operates franchise agreements in 49 U.S. states, Puerto Rico, and 28 additional countries.

10-03-2026

Invesco Mortgage Capital Inc. (NYSE: IVR) appointed Stephanie J. Larosiliere, a veteran fixed income expert with over two decades of experience and current Head of Business Strategy and Development for Invesco Ltd. Fixed Income in North America & APAC, to its Board of Directors as an executive director, effective March 6, 2026. The appointment is intended to strengthen stockholder engagement, alignment, and institutional investor relations. Don Liu, Chair of the Board, emphasized her expertise in fixed income markets and ability to identify emerging trends.

• ·Company is a real estate investment trust externally managed by Invesco Advisers, Inc.
• ·Investor Relations Contact: Gregory Seals, 404-439-3323
• ·Website: www.invescomortgagecapital.com

10-03-2026

On March 6, 2026, Robert D. Hormats, a member of American Tower Corporation's Board of Directors and Nominating & Corporate Governance Committee, notified the company that he will not stand for re-election at the 2026 Annual Meeting of Stockholders. His decision did not involve any disagreements with the company, and he will continue serving on the committee until the Annual Meeting.

10-03-2026

Advance Auto Parts, Inc. (NYSE: AAP) appointed Cynthia Jamison as an independent director to its Board of Directors on March 10, 2026, citing her extensive experience in retail, consumer products, and executive leadership. Jamison, former CFO of AquaSpy, Inc. and Partner at Tatum, LLC, currently chairs the board of Darden Restaurants, Inc. and serves on boards including International Flavors & Fragrances, Inc. The company operates 4,305 stores and serves 809 independently owned Carquest branded stores as of January 3, 2026.

• ·Jamison served as CFO of AquaSpy, Inc. (2010-2013), Partner at Tatum, LLC (1999-2009) leading CFO Practice for over 300 partners, and held C-suite roles at Chart House Enterprises, Allied Domecq Retailing USA, Kraft General Foods, and Arthur Andersen.
• ·Jamison previously chaired boards of Tractor Supply Company and Big Lots, Inc., and served on boards of Office Depot, Inc., B&G Foods, Cellu Tissue Holdings, Inc., and Horizon Organic Holdings Corp.

10-03-2026

On March 5, 2026, Thomas P. Mason announced his resignation from the board of directors of USA Compression GP, LLC, the general partner of USA Compression Partners, LP, including all board committees, effective March 31, 2026. The resignation was not due to any disagreement with the General Partner or Partnership on operations, practices, or policies. The 8-K filing was submitted on March 10, 2026.

• ·Resignation includes all committees of the Board
• ·Registrant details: Delaware incorporation, Commission File Number 1-35779, IRS EIN 75-2771546
• ·Principal executive offices: 8115 Preston Road, Suite 700, Dallas, Texas 75225
• ·Common units (USAC) traded on New York Stock Exchange

10-03-2026

On March 6, 2026, Nasim Golzadeh notified SoundThinking, Inc. of her resignation from positions as Managing Director, TechnoLogic and Executive Vice President, Investigative Solutions, effective March 31, 2026, to pursue an opportunity outside the public safety industry. The company filed an 8-K on March 10, 2026, disclosing the departure under Item 5.02. No replacement or further details on impact provided.

10-03-2026

Prudential Financial's Board of Directors appointed CEO Andrew Sullivan as Chairman effective March 10, 2026, succeeding Charles Lowrey, who resigned as Executive Chairman and director but will remain as a senior advisor through the end of Q2 2026 before retiring after 25 years of service. Lowrey previously served as CEO from 2018 to 2025 and Chairman from 2019 to 2025. The company reported approximately $1.6 trillion in assets under management as of December 31, 2025.

• ·Lowrey served as Executive Chairman beginning in 2025, Chief Executive Officer from 2018 to 2025, and Chairman from 2019 to 2025.
• ·Prudential has operations in the United States, Asia, Europe, and Latin America.

10-03-2026

ADM announced the appointment of Michael McMurray, former executive vice president and CFO of LyondellBasell Industries N.V., to its Board of Directors, effective March 9, 2026. McMurray, with over three decades of financial and strategic leadership experience from roles at Owens Corning and Royal Dutch Shell, will serve on the Audit and Sustainability and Technology committees. Board Chair and CEO Juan Luciano praised McMurray's expertise in finance, international business, strategy, and M&A as aligning with ADM's growth opportunities.

• ·McMurray holds a bachelor’s degree in Business Administration from Trinity University and an MBA from Tulane University.
• ·McMurray currently serves on the boards of Flowserve Corporation and the Children’s Advocacy Centers of Texas.

10-03-2026

AIR T INC filed an 8-K on 2026-03-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, or any financial metrics are disclosed.

10-03-2026

Procore Technologies, Inc. (NYSE: PCOR) announced on March 10, 2026, the appointments of Rachel Pyles as Chief Financial Officer Designate and Walt Hearn as Chief Revenue Officer Designate, effective immediately, succeeding Howard Fu and Larry Stack respectively on April 1, 2026, with Fu and Stack transitioning to strategic advisory roles. Both new executives bring extensive experience from Ansys, Inc. and other firms, with track records of driving revenue growth and operational excellence. The company reaffirms its Q1 FY26 and full-year FY26 financial guidance previously issued on February 12, 2026.

• ·Procore's Annual Report on Form 10-K for year ended December 31, 2025, filed February 24, 2026.
• ·Pyles has over 20 years of finance leadership experience.
• ·Hearn has 18-year tenure at Ansys.

10-03-2026

SolarEdge Technologies, Inc. announced that CFO Asaf Alperovitz will depart on June 9, 2026, to pursue a CFO role at another public company outside the industry, with the Board initiating a search for a replacement; he will remain through the transition period. The departure is unrelated to any financial, accounting, or operational disagreements. The company re-affirmed its Q1 financial guidance from February 18, 2026, and expressed optimism for profitable growth and a transformational 2026.

• ·Departure notification not related to any financial or accounting issue or disagreement over operations, policies, or practices.
• ·Annual Report on Form 10-K for year ended December 31, 2025, filed February 25, 2026.
• ·Q1 financial guidance originally provided February 18, 2026.

10-03-2026

Nature’s Sunshine Products reported strong Q4 2025 net sales growth of 4.7% YoY to $123.8M and FY2025 net sales up 5.7% YoY to $480.1M, with Adjusted EBITDA rising 16% to $11.9M and 21.7% to $49.4M respectively; GAAP net income swung to $4.1M profit in Q4 from a $0.3M loss and reached $19.5M for FY. However, Asia net sales declined 1.0% in Q4 and Latin America & Other fell 5.5% for FY, while SG&A expenses rose to 39.1% of sales in Q4 from 37.0%. Management noted 47% growth in digital channels but highlighted increased SG&A due to investments.

• ·Net cash provided by operating activities: $35.3M in FY2025 vs $25.3M in FY2024.
• ·Capital expenditures: $6.5M in FY2025 vs $11.0M in FY2024.
• ·FY2026 outlook: net sales $500-515M, Adjusted EBITDA $50-54M.
• ·No outstanding debt as of Dec 31, 2025.

10-03-2026

On March 4, 2026, the Board of Directors of Avalon GloboCare Corp. (ALBT) approved a one-time bonus of $175,000 to Chief Financial Officer Luisa Ingargiola for her contributions to the company's business and financial position during fiscal year 2025. The Board also approved an increase in annual fees for lead director Steven Saunders to $95,000. No other changes in directors or officers were reported.

10-03-2026

LB Pharmaceuticals Inc. (Nasdaq: LBRX), a late-stage biopharmaceutical company developing therapies for neuropsychiatric diseases including schizophrenia and bipolar depression, announced on March 9, 2026, the appointment of Robert Lenz, M.D., Ph.D., a neuroscience R&D veteran with over 20 years of experience, to its Board of Directors. Dr. Lenz, formerly EVP and Head of R&D at Neumora Therapeutics and in senior roles at Amgen Inc. and Abbott Laboratories, will support the advancement of lead candidate LB-102 into late-stage clinical development. No compensation details or other changes were disclosed.

• ·Dr. Lenz earned M.D. and Ph.D. from University of Maryland School of Medicine; neurology residency at University of California - Los Angeles.
• ·Risk factors detailed in Form 10-Q for quarter ended September 30, 2025.

10-03-2026

Marsh announced Nick Studer as the new President and CEO of Marsh Risk effective April 1, 2026, succeeding Martin South, who transitions to Chief Client Officer in an enterprise-wide role; both will report to John Doyle, President and CEO of Marsh, and remain on the Executive Committee. The changes aim to accelerate growth, enhance client value, and leverage AI and technologies. Marsh, with annual revenue over $27B and more than 95,000 colleagues across 130 countries, expects to announce new CEOs for Oliver Wyman and Marsh Management Consulting by April 1.

• ·Nick Studer joined Oliver Wyman in 1997 and became its CEO in 2021.
• ·Martin South rejoined Marsh in 2007, previously served as CEO of Marsh Risk since 2022, and held roles at Zurich Financial Services.

10-03-2026

Virtuix Holdings Inc. reported nine-month FY2026 net sales of $3.0M, up 41% YoY from $2.1M, with gross margin improving to 29% from -17% and operating expenses down 45% to $6.3M, though net loss narrowed to $6.9M from $12.0M. However, Q3 FY2026 net sales declined 24% YoY to $1.0M from $1.3M due to a shift from backlog fulfillment to new customer sales, with Q3 net loss widening to $2.7M from $2.0M despite gross margin rising to 30% from -2%. Strategic highlights include Nasdaq listing on Jan 27, 2026, Meta collaboration, European expansion, and defense test unit sales.

• ·Cash used in operating activities: $5.5M in nine months FY2026 (down from $6.3M YoY)
• ·European Omni One Core shipments to begin April 13-24, 2026
• ·Test units of VTW sold to U.S. Military Academy at West Point, U.S. Air Force Academy, and Yokota Air Force Base
• ·Nasdaq listing and closing bell on Jan 27 and March 4, 2026
• ·Manufacturing capacity scaled to 3,000 units per month

10-03-2026

On March 6, 2026, Sean Steves notified Casella Waste Systems, Inc. of his resignation as Senior Vice President and Chief Operating Officer of Solid Waste Operations, effective March 20, 2026, to pursue opportunities outside the waste and recycling industry. The departure was not due to any disagreement with the company's operations, policies, or practices. The company has initiated a search for a replacement.

• ·Filing date: March 10, 2026
• ·Date of earliest event reported: March 6, 2026

10-03-2026

On March 4, 2026, Harry E. Sloan, a director of Starz Entertainment Corp., notified the Board that he will not stand for re-election at the upcoming 2026 Annual Meeting of Shareholders to reduce his overall number of board mandates. His decision was not due to any disagreement with the company's operations, policies, or practices. Sloan will continue serving on the Board until the expiration of his current term at the 2026 Annual Meeting.

• ·Filing date: March 10, 2026
• ·Event reported date: March 4, 2026
• ·Company headquartered at 250 Howe Street, 20th Floor, Vancouver, British Columbia V6C 3R8 and 1647 Stewart Street, Santa Monica, California 90404
• ·Securities: Common Shares (STRZ) on Nasdaq Global Select Market

10-03-2026

Equinix, Inc. (Nasdaq: EQIX) announced the appointment of Olivier Leonetti as Chief Financial Officer effective March 16, 2026, succeeding Keith Taylor, who is retiring after 27 years with the company following its evolution from startup to industry leader with over $9B in annualized revenue. Leonetti brings more than 30 years of financial leadership from roles as CFO at Eaton, Johnson Controls, Zebra Technologies, and Western Digital, as well as senior positions at Dell and Amgen. Taylor will serve as a special advisor for approximately one year to ensure a smooth transition.

• ·Keith Taylor joined Equinix in 1999.
• ·Press release issued March 10, 2026.
• ·Forward-looking statements highlight risks including inflation, foreign currency fluctuations, energy market volatility, supply chain constraints, and competition.

10-03-2026

On March 5, 2026, the Board of Directors of Citizens, Inc. approved an amendment to CEO Jon Stenberg's Executive Employment Agreement to better align compensation with peer market data for retention and motivation purposes. Effective April 1, 2026, his base salary increases from $500,000 to $600,000 (20% increase); starting in 2026, target short-term incentive rises from $400,000 to $480,000 (20% increase), and long-term incentive target from $450,000 to $540,000 (20% increase). All other terms remain unchanged.

• ·Amendment filed as Exhibit 10.1.
• ·Event reported on March 5, 2026; filing dated March 10, 2026.

10-03-2026

Innodata Inc. entered into a new employment agreement with Rahul Singhal, President and Chief Revenue Officer, effective January 1, 2026, providing an annual base salary of $500,000 and a target annual cash bonus of at least 75% of base salary. The agreement includes generous severance terms of 200% of base plus recent bonus (paid over 24 months) for termination without cause or good reason resignation, and 300% lump sum plus extended benefits in a change of control scenario. Additionally, an amendment to CEO Jack Abuhoff's employment agreement clarifies 100% payout acceleration for tiered performance awards upon certain terminations.

• ·Severance benefits include continued medical/dental for 24 months, life/disability insurance for 24 months, and accelerated vesting of equity awards.
• ·Change of control benefits include medical/dental for up to 36 months and life/disability insurance for 36 months.
• ·Agreements contain restrictive covenants: confidentiality, non-compete, and non-interference.
• ·Amendment to Abuhoff's agreement effective March 9, 2026, on original employment agreement from February 1, 2009.

10-03-2026

Shoulder Innovations reported strong Q4 2025 net revenue of $14.4M, up 65% YoY from $8.7M, and full-year 2025 revenue of $47.3M, up 50% YoY from $31.6M, driven by 62% more implant systems sold (1,976 units) and 61% growth in surgeons (134 total). However, gross margins slightly declined to 76.7% in Q4 (from 77.6%) and 76.5% for the year (from 77.0%), while SG&A expenses rose 79% to $16.3M in Q4 and R&D surged 176% to $3.2M, widening Q4 operating loss to $8.5M (from $3.5M) and full-year net loss to $40.4M (from $15.6M). The company guided FY2026 revenue to $62M-$65M (31-37% growth) and appointed Drew Hykes to its Board.

• ·Cash and cash equivalents plus marketable securities totaled $124.3M as of December 31, 2025.

10-03-2026

On March 9, 2026, Tejon Ranch Co. Director Kenneth G. Yee informed the company he will not stand for reelection at the 2026 annual meeting, prompting the Board to reduce its size from 10 to 9 directors effective upon adjournment of that meeting and nominate the remaining nine incumbents. Board Chair Norman J. Metcalfe and Director Gregory S. Bielli stated their intent to retire and not seek reelection at the 2027 annual meeting if reelected in 2026, with plans to further reduce the Board to 7 directors by then. Additionally, the Board eliminated its Executive Committee effective immediately.

10-03-2026

GEE Group Inc. announced the retirement and resignation of Director William M. Isaac from its Board effective March 6, 2026, for health and other reasons, after serving since 2015. Chairman and CEO Derek Dewan praised Isaac's contributions over the past decade, noting his background as former Chairman of the FDIC. The announcement includes details on the company's staffing services across various brands but reports no financial impacts or operational changes.

• ·Isaac served on the Board for approximately 10 years since 2015
• ·Contact information: Kim Thorpe, 630.954.0400, invest@geegroup.com

10-03-2026

On March 5, 2026, Kris Shah resigned from the Board of Directors of Profound Medical Corp., effective immediately, with no disagreements with the company noted. Frank Baylis was immediately appointed to fill the vacancy, serving until the 2026 annual meeting of stockholders or until his successor is elected. Baylis will receive standard non-employee director compensation, including a pro-rated $50,000 annual retainer and an annual equity award.

• ·No arrangements or understandings between Frank Baylis and any other person for his appointment
• ·No family relationships between Frank Baylis and any director or executive officer
• ·No material interest transactions for Baylis under Item 404(a) of Regulation S-K
• ·Baylis entered into the company's standard form of indemnification agreement
• ·Company's common shares trade as PROF on The Nasdaq Stock Market

10-03-2026

On March 4, 2026, Donald K. Boswell, a director of Financial Institutions, Inc. and its subsidiary Five Star Bank, notified the Board of his decision not to stand for re-election at the 2026 Annual Meeting of Shareholders, with retirement effective immediately following the meeting after nine years of service. The decision reflects his intent to pursue outside interests and did not arise from any disagreement with the Company, its Board, management, or operations, policies, or practices.

10-03-2026

Leonardo DRS, Inc. (Nasdaq: DRS) announced the appointment of Reuben Jeffery III to its Board of Directors, effective April 1, 2026, succeeding David W. Carey who is retiring at the end of his term. Jeffery brings extensive experience from roles at Rockefeller & Co., U.S. government positions including Under Secretary for Economic, Energy, and Agricultural Affairs and Chairman of the Commodity Futures Trading Commission, and 18 years at Goldman Sachs. Board Chair Frances (Fran) Fragos Townsend stated that Jeffery's expertise in public policy, global finance, and governance will support the company's growth strategy and long-term value creation.

• ·Jeffery's prior U.S. government roles: Under Secretary for Economic, Energy, and Agricultural Affairs (2002-2009), Chairman of the Commodity Futures Trading Commission, Special Assistant to the President on the National Security Council, Advisor to Ambassador Bremer in Iraq, Executive Director of the Coalition Provisional Authority’s office in the Pentagon.
• ·Jeffery's education: B.A. from Yale University, J.D. and M.B.A. from Stanford University.
• ·Investor Relations contact: Steve Vather, +1 703 409 2906, stephen.vather@drs.com.
• ·Media contact: Carrie Robinson, +1 321 266 7691, carrie.robinson@drs.com.

10-03-2026

On March 4, 2026, the Board of Directors of Plug Power Inc. appointed Jose Luis Crespo, the current Chief Executive Officer and President, as a Class III director to serve until the 2026 annual meeting of stockholders or until his successor is elected. No additional compensation, new arrangements, family relationships, or related-person transactions were associated with the appointment. Mr. Crespo's existing compensation as CEO and President remains unchanged.

• ·Mr. Crespo joined Plug Power in 2014 as Vice President of Business and International Sales, with subsequent promotions including Chief Revenue Officer (Nov 2024-Mar 2026), General Manager of Hypulsion (2016), and various EVP roles.
• ·Prior to Plug Power, Mr. Crespo was VP of International Value Stream at Smiths Power (2009-2013).
• ·Mr. Crespo holds an MBA from University of Phoenix and a Telecommunications Engineering degree from Engineering University of Madrid, Spain.
• ·Mr. Crespo serves on the board of AccionaPlug S.L.